Adam Zieba

Adam Zieba has extensive experience in the field of biomedical engineering and immunology, currently serving as Scientist II in Cell Therapy at Tome Biosciences since March 2022. Prior roles include various scientific positions at TCR² Therapeutics Inc. from June 2017 to March 2022 and a research assistant position at Tufts University from September 2013 to May 2017, where notable contributions included developing 3D models for studying obesity-related inflammation and wound healing. Earlier, Adam held an engineering intern position at Enumeral Biomedical Holdings, Inc. focused on quality control for protein microarray devices and a crew member role at Dunkin Donuts, recognized as Employee of the Month in June 2013. Adam completed both a Master of Science and a Bachelor of Science in Biomedical Engineering at Tufts University.